Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain assessment in advanced dementia: Validity of the German PAINAD (BESD)
DRKS00000525Phase 3Completed
- Sponsor
- Agaplesion Bethesda Klinik Ulm
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxycodone in pain and Dementia (2 arms), sponsored by Agaplesion Bethesda Klinik Ulm. Started Aug 2010; status: completed.
02
Drugs
oxycodone
03
Conditions
painDementia
Beyond the preview
Go deeper on DRKS00000525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000525.